key: cord-0774084-wpmgh95t authors: Ma, Junxiong; Zhou, Suduo; li, Na; Dong, Xuejie; Maimaitiming, Mailikezhati; Jin, Yinzi; Zheng, Zhi‐Jie title: Admissions for and Quality of Care of ST‐Segment‐Elevation Myocardial Infarction in the Post COVID‐19 Era in China date: 2021-05-22 journal: Int J Clin Pract DOI: 10.1111/ijcp.14379 sha: 163eb5e8995da1c1e735dd9912c27d9a021615c5 doc_id: 774084 cord_uid: wpmgh95t OBJECTIVE: To evaluate changes in admission rates for and quality of care of ST‐Segment‐Elevation Myocardial Infarction (STEMI) during the period of the coronavirus disease 2019 (COVID‐19) outbreak and post COVID‐19 era. METHODS: We conducted a retrospective cohort study of patients with STEMI in the outbreak era (between January 23, 2020 and March 27, 2020), and the post era (between March 28, 2020, and July 31, 2020) in Suzhou Province, drawn from the China Chest Pain Center Database. RESULTS: 1965 STEMI admissions were enrolled. During the corresponding period of 2019 to the post COVID‐19 era, there were a 53% and 38% fall in admissions in outbreak and the post era. There remained a gap in actual number of admissions at 306 and the predicted number that might be at 497. An estimated 26 deaths due to STEMI would have been caused by not seeking health care while no one died from COVID‐19. The percentage of STEMI cases transferred by ambulance decreased from 9.3% to 4.2% (P=0.013). Door‐to‐balloon and the FMC‐to‐device median (q1, q3) time increased from 17.5 (10.0, 46.0) and 52.0 (12.0, 86.0) minutes to 34.0 (15.0, 48.0) and 63.0 (15.0, 94.0) minutes, respectively (p=0.001, p=0.005), and rate of PCI practice declined from 71.3% to 60.1% (p=0.002). CONCLUSIONS: The impact of public health restrictions in the post COVID‐19 era is significant, and may lead to unexpected out‐of‐hospital deaths and compromised quality of STEMI care. Delay or absence in presentation in STEMI patients should be continuously considered to avoid the secondary disaster of the pandemic. System delay should be modifiable for reversing the worse clinical outcomes from the COVID‐19 outbreak, by coordination measures with focus on the balance between timely PCI procedure and minimizing contamination of cardiac catheterization rooms. The coronavirus disease 2019 pandemic is challenging health care systems in unprecedented ways, and the effects will last for decades to come. 1 Most countries have implemented stringent infection-control measures, including but not limited to social distancing measure, emergency infection protocols instituted in hospitals to contain COVID-19, and adjustment of clinical services. The response to COVID-19 can compromise quality of care for non-COVID-19 diseases, especially for ST-Segment-Elevation Myocardial Infarction (STEMI), the deadliest and most time-sensitive acute cardiac event. [2] [3] [4] A number of studies have reported substantial declines in the number of patients presenting with STEMI and the number of percutaneous coronary intervention (PCI) practice, the typically recommended treatment, during the coronavirus outbreak. [5] [6] [7] [8] [9] However, little is known regarding the impact of the post COVID-19 era on admission rate and quality of STEMI care. China has recovered from the initial outbreak and is experiencing the defense of the coronavirus bounce back. There are two major public health concerns with respect to STEMI care in the post COVID-19 era: (i) delays in presentation, and (ii) delays in treatment. [10] [11] [12] First, less is clear on whether there have been a rebound in STEMI presentation. Several studies have reported a surge in STEMI admission rate correlating with the fading of the first wave of the COVID-19 outbreak. 13 Changes in lifestyle pattern (e.g. physical inactivity and weight gain) during lockdown, has been suggested as a potential factor for exacerbating the population cardiovascular risk profile and creating a greater number of vulnerable coronary patients. 14, 15 Even yet after the wave of the COVID-19 outbreak, the emphasis on social distancing might have inappropriately convinced patients to avoid in-person health care. The lack of knowledge on personal protection measures compounded by fear of contracting an infection may make patients much less likely to seek help. Thus, an increasing number of patients presenting with STEMI at high coronary risk do not seek health care in a timely manner, which will lead to more unexpected out-of-hospital deaths and cause the secondary disaster of the pandemic. Second, little is known regarding how the post COVID-19 era influenced the delivery of STEMI care in terms of care processes based on the recommended guidelines, once patients Accepted Article entered the health care system. STEMI cases require rapid coordination of care beginning at the time of symptom onset. However, the emergency infection protocols (e.g., coronavirus screening upon hospital arrival) still persistent, which could result in a considerable delay in timely treatment, and may impact optimal treatment delivery for patients presenting with STEMI. 16, 17 It is a great challenge for health care system to make a balance between identifying patients for PCI procedure, regardless of their coronavirus status, and maintaining the safety of health care workers who may be exposed to the virus as well as minimizing contamination of cardiac catheterization rooms. Thus, it is warranted to evaluate how is the health care system's resilience to recover from the coronavirus outbreak, for operational integrity with respect to STEMI cases. To fill this gap, this study aims to investigate the admissions for and quality of care of STEMI in the post COVID-19 era. The objectives of this study are two-fold as follows: (1) Data for this study were obtained from the China Chest Pain Center (CPC) Database (http://data.chinacpc.org/), a nationwide clinical registry for collecting data of all consecutive patients diagnosed with STEMI enrolled by the accredited hospital-based CPCs. The data elements include patient demographics, prehospital treatment, presenting features, in-hospital medication and reperfusion practice, clinical outcomes and discharge. This national audit is supervised by the the China Cardiovascular Association (CCA), located in the city of Suzhou. Accredited hospitals are instructed to submit consecutive eligible patients to the database in real time. Improvement in adherence to data reporting is facilitated through monthly and quarterly hospital-specific performance feedback reports. We extracted the data from the This article is protected by copyright. All rights reserved CPCs in Suzhou, which has been one of the pilot cities to implement the highest restrictions of lockdown. Suzhou has also taken the lead to announce the unlock and resumption of work and production. We conducted a retrospective cohort study of patients presenting with STEMI between January, 2017 and July, 2020 in Suzhou. The COVID-19 outbreak era was defined as period between January 23, 2020 and March 27, 2020, corresponding to the introduction of the highest restrictions of movement and a public health drive to combat rising cases in Suzhou. The post COVID-19 era was defined as period between March 28, 2020, and July 31, 2020 corresponding to the announcement of resumption of work and production by the Suzhou Government. Data for this analysis were included from all the accredited CPCs in Suzhou in each month of the year 2017-2020 until the end of July 2020. Our study took the advantage that data was prospectively collected and data checks and validations took place. The primary outcome was number of monthly STEMI admissions, and the secondary outcomes was quality metrics of STEMI care in terms of prehospital process, in-hospital process, and clinical outcome. The quality metrics were selected, based on the Class I Recommendations from the most updated American College of Cardiology/American Heart Association (ACC/AHA) clinical practice guidelines (Supplementary Table 1 ). 18 The pre-hospital process indicators included percentage of onset-to-FMC (EMS arrival or walk-in to ED) time ≤60 min, percentage of ambulance ECG to door time ≤15 min, percentage of cases arriving at hospital by ambulance, percentage of ambulance ECG. In-hospital process indicators included percentage of β-blocker usage, percentage of door-to-balloon time ≤60 min, percentage of FMC-to-device time ≤90 min, percentage of onset-to-device time ≤120 min, door-to-balloon time, FMC-to-device time, onset-to-device time, and PCI rate. Outcome indicator is in-hospital mortality. Demographic and clinical characteristics for this study included age, sex, presenting chest pain status, vital signs (respiratory rate, pulse frequency, heart rate, blood pressure), and Killip class. This article is protected by copyright. All rights reserved Fisher's exact test was used to compute 95% confidence intervals for each quality metric. P-values <0.05 were considered statistically significant. All statistical analyses were conducted in R software (R Foundation for Statistical Computing, Vienna, Austria, and Version 3.6.3). The study cohort comprised 1965 admissions for STEMI, of which 98 and 313 were in This article is protected by copyright. All rights reserved the COVID-19 outbreak and the post COVID-19 era, respectively. Of those 306 patients with STEMI in the post COVID-19 era, 17.6% were women, with a mean age of 60.7 (SD 14.6) years. During the COVID-19 outbreak, 26.4% of patients were women and the mean age was 65.2 (SD 12.3), significantly higher (P=0.008, P=0.005) than those in the post COVID-19 era, respectively ( Table 1) . Table 2 . Based on the formula that (Predicated numbers-actual numbers)* 8% (the average death rate), the predicated death number due to the lack of seeking medical care was 26. This article is protected by copyright. All rights reserved This is, to our knowledge, the first study to investigate the changes in STEMI admissions for and quality of care in the post COVID-19 era, with the fading of the COVID-19 outbreak. Although we observed the reversed increase in STEMI admissions, there remained a gap in the number of the post COVID-19 era and predicted numbers based on the admissions in 2018-2019. We explored to predict that 26 deaths due to STEMI would have been caused by not seeking health care, while no one died from COVID-19 with the total number of infections was 87, in the post COVID-19 era. According to the incidence of STEMI about 55/100,000 in China, it can be predicated that there will be nearly 300,000 STEMI not seeking health care because of COVID-19, which could lead to over 20,000 death in the post COVID-19 era. 22 Quality of STEMI care remained suboptimal in the post COVID-19 era, comparing with that in the corresponding periods in 2018-2019, especially This article is protected by copyright. All rights reserved for percentage of cases transferred by EMS, and in-hospital process indicators. Although in-hospital mortality declined during the COVID-19 outbreak to the post COVID-19 era, the change was not significant. These findings suggest that the impact of public health restrictions in the post COVID-19 era is still significant, and may lead to unexpected out-of-hospital deaths and compromised quality of care among patients with STEMI. Our findings on the impact of the COVID-19 outbreak are consistent with prior studies that have already reported on decline in admission rate and prolonged time to PCI practice during the COVID-19 outbreak. 9 Previous studies using the self-controlled case series method provided evidence that COVID-19 may increase the risk of STEMI during the acute phase of infection. 23 However, the reduced number of admissions during the COVID-19 outbreak is likely to have resulted in increases in out-of-hospital deaths and long-term complications. 6 Our current study focuses on the post COVID-19 era, with the advantage that data is prospectively collected and data validation is facilitated through monthly and quarterly data audit and feedback. A nationwide study in UK reported a 23% decrease in admissions for STEMI from 2019 to the end of March, 2020, and admission rates for STEMI had partly recovered but remained about 16% below baseline levels by the end of May, 2020. 6 While a few studies indicated that there might be a post COVID-19 rebound for STEMI admissions. 13 Our current study adds the evidence from the low-and middle-income countries, showing a 26 Given the conflict between time required for coronavirus nucleic acid detection and early PCI for STEMI, thrombolysis is conducted in priority in the emergency room, and sample for the coronavirus nucleic acid detection is sent after the start of thrombolysis. Since the results of nucleic acid detection should be waited for several hours that must lead to delays in treatment, cardiologists can make the treatment decision after full consideration of the benefit to risk ratio; if the possibility of having COVID-19 based on the respiratory symptoms and epidemiological exposure history is clinically small, PCI can be conducted immediately in an isolation ward. In our study, all the patients enrolled were negative for COVID-19. 27 We have analyzed all the components of the treatment time including patient delay and system delay. Notably, the extension in patient delay showed no significant during the post COVID-19 era and the corresponding periods of 2018-2019. We This article is protected by copyright. All rights reserved outbreak. Although the explication of reasons for these changes is beyond the scope of our study, a number of prior studies pointed out the fact that elderly and female patients with STEMI have higher in-hospital mortality or worse clinical outcomes than the young and the male. 28, 29 Nevertheless, data of our study provides additional information that neither the risk use of PCI therapy. Therefore, it is imperative to improve the health care system's ability to maintain care coordination for timely PCI with respect to STEMI cases. Prior studies have shown that a dedicated coordinator from a CPC could play a critical role in maintaining This article is protected by copyright. All rights reserved coordination of care, in charge of coordination of the hospital and EMS agencies, and collaboration of multidisciplinary teams including the cardiology department, emergency department, infections department, pneumology department, and the medical laboratory department. 16, 32 Limitations This study has several limitations. First, in a dynamic cohort study, there will be concerns related to confounding, bias, and temporal trends in quality of care that may limit the validity of the findings. However, we compared the changes in the quality metrics of care era on quality of care. Second, with one city selected in the sampling frame, the national representativeness of the study sample cannot be ascertained. However, the city of Suzhou is one of the first cities having responded to the national call for public health measures for combating the pandemic, and having developed accredited CPCs to guide standardized pre-hospital and in-hospital STEMI care in a regional level in China. We believe that the selected sample is generally representative of the health and economic development in the most developed urban China. It is key to note that the impact of public health restrictions in the post COVID-19 era is significant, and may lead to unexpected out-of-hospital deaths and negatively influence quality of care among patients with STEMI. Delay or absence in presentation in STEMI patients should be continuously considered to avoid the secondary disaster of the pandemic. System delay should be modifiable for reversing the worse clinical outcomes from the COVID-19 outbreak, by coordination measures with focus on the balance between timely PCI procedure and minimizing contamination of cardiac catheterization rooms. This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved This article is protected by copyright. All rights reserved In-hospital mortality, n (%) World Health Organization. WHO Director-General's opening statement at the Virtual Panel Discussion: Governance and Social Contract within a changing International Context: Making Universal Healthcare, universal. Switzerland: World Health Organization Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular disease: a systematic review A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far? Impact of the COVID-19 Pandemic on Percutaneous Coronary Intervention in England: Insights From the British Cardiovascular Intervention Society PCI Database Cohort COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease Accepted Article This article is protected by copyright. All rights reserved Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP) Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI) Considerations for an Individual-Level Population Notification System for Pandemic Response: A Review and Prototype Post COVID-19 Acute Myocardial Infarction Rebound Lifestyle at Time of COVID-19: How Could Quarantine Affect Cardiovascular Risk The potential long-term impact of the COVID-19 outbreak on patients with non-communicable diseases in Europe: consequences for healthy ageing Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual? EAPCI Position Accepted Article This article is protected by copyright. All rights reserved Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction Forecasting seasonals and trends by exponentially weighted averages The Holt-winters forecasting procedure ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data China cardiovascular diseases report 2018: an updated summary Acute COVID-19 and the Incidence of Ischemic Stroke and Acute Myocardial Infarction Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People's Hospital Recommendations from the Peking Union Medical College Hospital for the management of acute myocardial infarction during the COVID-19 outbreak A treatment strategy for acute myocardial infarction and personal protection for medical staff during the COVID-19 epidemic: the Chinese experience This article is protected by copyright. All rights reserved Transfer-in